Search results
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 2 days agoPatients like Price are struggling to afford a blockbuster class of weight-loss medications called...
Intra-Cellular Therapies (NASDAQ:ITCI) Given New $107.00 Price Target at Canaccord Genuity Group
ETF DAILY NEWS· 4 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its target price increased by Canaccord Genuity Group from $100.00 to $107.00 in a research note
Intra-Cellular Therapies (NASDAQ:ITCI) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoCantor Fitzgerald’s price objective indicates a potential upside of 66.37% from the stock’s previous close. Several other equities analysts have also weighed in on the company ...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 1 day ago“The handwriting is on the wall regarding Roctavian,” Piper Sandler analyst Christopher Raymond...
Investing in Taysha Gene Therapies Inc
Knox Daily· 6 days agoB now holds 16,466,667 shares, worth roughly $37.38 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...
As ketamine therapy booms, industry insiders worry about patient safety
Market Watch· 2 days agoThe incident raises broader questions about at-home ketamine therapy, the doctors wrote. Guidelines...
Intra-Cellular Therapies Inc [ITCI] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 6 days agoRobert W. Baird initiated its Intra-Cellular Therapies Inc [ITCI] rating to an Outperform in a research note published on January 03, 2024; the price target ...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 1 day agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Taysha Gene Therapies Inc (TSHA) Shares Rise Despite Market Challenges – News Heater
NewsHeater· 4 days agoTaysha Gene Therapies Inc (NASDAQ: TSHA) has seen a rise in its stock price by 2.85 in relation to its previous close of 2.46. Is It Worth Investing in Taysha Gene Therapies ...
Insider Selling: Mates Sharon, Intra-Cellular Therapies Inc [ITCI] Chairman, President & CEO...
Knox Daily· 3 days agoUpon closing the transaction, the insider’s holdings decreased to 7,345 shares, worth approximately $0.0. As published in their initiating research note from Robert W. Baird ...
